PMID: 11331434May 2, 2001Paper

History of the development of arsenic derivatives in cancer therapy

The Oncologist
Samuel Waxman, K C Anderson

Abstract

Arsenic is a natural substance that has been used medicinally for over 2,400 years. In the 19th century, it was the mainstay of the materia medica. A solution of potassium arsenite (Fowler's solution) was used for a variety of systemic illnesses from the 18th until the 20th century. This multipurpose solution was also primary therapy for the treatment of chronic myelogenous leukemia until replaced by radiation and cytotoxic chemotherapy. The past 100 years have seen a precipitous decline in arsenic use and, by the mid-1990s, the only recognized indication was the treatment of trypanosomiasis. Much of this decline was due to concerns about the toxicity and potential carcinogenicity of chronic arsenic administration. The rebirth of arsenic therapy occurred in the 1970s when physicians in China began using arsenic trioxide as part of a treatment for acute promyelocytic leukemia (APL). Their accumulated experience showed that a stable solution of arsenic trioxide given by intravenous infusion was remarkably safe and effective both in patients with newly diagnosed APL leukemia and in those with refractory and relapsed APL. The mechanisms of action of arsenic derivatives in this disease and other malignancies are many and include ind...Continue Reading

References

Apr 1, 1992·Journal of the History of Medicine and Allied Sciences·K Konkola
Jun 1, 1982·British Journal of Cancer·J CuzickD A Price Evans
Jan 1, 1997·Current Opinion in Oncology·T Büchner
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·J ZhuH de Thé
Aug 15, 1997·The Biochemical Journal·G M Cohen
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S L WoldenS S Donaldson
Nov 5, 1998·The New England Journal of Medicine·S L SoignetR P Warrell
Nov 5, 1998·The New England Journal of Medicine·R E Gallagher
May 18, 1999·Journal of the National Cancer Institute·G Kroemer, H de Thé

❮ Previous
Next ❯

Citations

Jul 20, 2007·Biological Trace Element Research·Ingrid FalnogaMagda Tusek-Znidaric
Mar 16, 2013·Annals of Hematology·Athena KritharisDaniel R Budman
Oct 22, 2013·Cancer Chemotherapy and Pharmacology·Laura HorsleyUNKNOWN Cancer Research UK Drug Development Office Phase I clinical trial
Aug 19, 2011·Apoptosis : an International Journal on Programmed Cell Death·Lianlian ShenJianwei Zhou
Jun 6, 2007·Journal of Bioenergetics and Biomembranes·Helen M PetterssonSven Påhlman
Apr 15, 2010·Biological Trace Element Research·Zhi-Fang Wang, Xiong Guo
Apr 19, 2011·European Journal of Drug Metabolism and Pharmacokinetics·Imane AjanaStéphane Gibaud
May 12, 2005·Blood Reviews·Daniel V T Catenacci, Gary J Schiller
Jul 20, 2002·Trends in Molecular Medicine·Robert Z Orlowski, Albert S Baldwin
Jul 25, 2013·Inorganic Chemistry·Isolda Romero-Canelón, Peter J Sadler
Sep 27, 2003·European Journal of Biochemistry·Merlijn BazuineJ Antonie Maassen
Mar 6, 2003·Reviews in Clinical and Experimental Hematology·Deepak GuptaKenneth C Anderson
Dec 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jian-Hua MaoSai-Juan Chen
Oct 18, 2005·DNA and Cell Biology·Shohreh NafisiHeidar-Ali Tajmir-Riahi
Jan 20, 2006·Nucleic Acids Research·Yadong ZhangFei Chen
Jul 14, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Michael F HughesDavid J Thomas
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Der-Ren HwangChau-Ting Yeh
Dec 19, 2007·Molecular and Cellular Biology·Michael D WilsonPerry L Howard
Sep 23, 2011·Canadian Journal of Microbiology·Sukhvinder KaurArif Ali
May 7, 2009·Molecular Cancer Therapeutics·Shannon M MatulisLawrence H Boise
Dec 25, 2010·The Journal of Clinical Investigation·Elspeth M BeauchampAykut Uren
Jan 29, 2005·Blood·Nicos KarasavvasDavid W Golde
Feb 19, 2010·Folia Histochemica Et Cytobiologica·Magdalena IzdebskaDariusz Grzanka
Jul 11, 2006·International Journal of Environmental Research and Public Health·Clement G YedjouPaul B Tchounwou
Mar 8, 2014·Inorganic Chemistry·Linhong ZhaoYangzhong Liu
Jun 19, 2014·International Journal of Hematology·Junmin LiZhenyi Wang
Jan 19, 2005·Anti-cancer Drugs·Jiong HuZhu Chen
Dec 29, 2004·Leukemia & Lymphoma·Markus Thomas RojewskiHubert Schrezenmeier

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.